Brand Name | Status | Last Update |
---|---|---|
enoxaparin sodium | ANDA | 2025-05-26 |
enoxiluv kit | unapproved drug other | 2024-10-05 |
lovenox | New Drug Application | 2025-06-03 |
Code | Description |
---|---|
J1650 | Injection, enoxaparin sodium, 10 mg |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Thromboembolism | D013923 | — | — | — | 2 | 7 | 4 | 2 | 14 |
Venous thromboembolism | D054556 | EFO_0004286 | I74 | — | 2 | 7 | 2 | 2 | 12 |
Thrombosis | D013927 | — | — | 1 | 1 | 1 | 3 | 2 | 8 |
Venous thrombosis | D020246 | — | I82.40 | — | 1 | 1 | 3 | 2 | 7 |
Acute coronary syndrome | D054058 | EFO_0005672 | — | — | — | 2 | 2 | — | 4 |
Unstable angina | D000789 | EFO_1000985 | I20.0 | — | — | 1 | 1 | — | 2 |
Obesity | D009765 | EFO_0001073 | E66.9 | — | — | — | 1 | — | 1 |
Renal dialysis | D006435 | EFO_0010690 | Z99.2 | — | — | — | 1 | — | 1 |
Atrial fibrillation | D001281 | EFO_0000275 | I48.0 | — | — | — | 1 | — | 1 |
Syndrome | D013577 | — | — | — | — | — | 1 | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Myocardial infarction | D009203 | EFO_0000612 | I21 | — | 1 | 4 | — | — | 4 |
Infarction | D007238 | EFO_0009463 | — | — | 1 | 4 | — | — | 4 |
Lung neoplasms | D008175 | — | C34.90 | — | 1 | 1 | — | — | 2 |
Small cell lung carcinoma | D055752 | — | — | — | 1 | 1 | — | — | 2 |
Hip fractures | D006620 | EFO_0003964 | S72.00 | — | — | 2 | — | — | 2 |
Pulmonary embolism | D011655 | EFO_0003827 | I26 | — | — | 1 | — | 1 | 2 |
Embolism | D004617 | — | — | — | — | 1 | — | 1 | 2 |
Covid-19 | D000086382 | — | U07.1 | — | — | 1 | — | — | 1 |
Inferior wall myocardial infarction | D056989 | EFO_1000983 | — | — | — | 1 | — | — | 1 |
Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | — | 1 | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Ovarian neoplasms | D010051 | EFO_0003893 | C56 | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Thrombocytopenia | D013921 | HP_0001873 | D69.6 | — | — | — | — | 1 | 1 |
Drug common name | Enoxaparin sodium |
INN | enoxaparin sodium |
Description | Enoxaparin sodium, sold under the brand name Lovenox among others, is an anticoagulant medication (blood thinner). It is used to treat and prevent deep vein thrombosis (DVT) and pulmonary embolism (PE) including during pregnancy and following certain types of surgery. It is also used in those with acute coronary syndrome (ACS) and heart attacks. It is given by injection just under the skin or into a vein. It is also used during hemodialysis.
|
Classification | Oligosaccharide |
Drug class | heparin derivatives and low molecular weight (or depolymerized) heparins |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | 679809-58-6 |
RxCUI | — |
ChEMBL ID | CHEMBL1201476 |
ChEBI ID | — |
PubChem CID | 772 |
DrugBank | DB01225 |
UNII ID | 8NZ41MIK1O (ChemIDplus, GSRS) |